For Investors

Press Releases

ReWalk Robotics Reports Second Quarter 2021 Financial Results

08/09/21

— Second Quarter 2021 Total Revenue of $1.4 million — — Second quarter 2021 marks the fourth consecutive quarter over quarter growth — — Strong balance sheet with $ 64.2 million in cash, as of June 30 , 2021— MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Aug.

Read More
Read More

ReWalk Robotics to Report Second Quarter 2021 Financial Results on August 9, 2021

08/04/21

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Aug. 04, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its second quarter 2021 financial results on Monday, August 9, 2021 , before the U.S.

Read More
Read More

ReWalk Robotics Appoints Senior Biotech Executive, Jeannine Lynch, as Vice President of Strategy and Market Access

08/02/21

Ms. Lynch will lead ongoing building and implementation of ReWalk’s market access and reimbursement programs MARLBOROUGH, Mass. , Aug. 02, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd.  (Nasdaq: RWLK) (“ReWalk” or the “Company”), a manufacturer of robotic medical devices for individuals with lower

Read More
Read More

ReWalk Robotics Reports First Quarter 2021 Financial Results

05/11/21

— First Quarter 2021 Total Revenue of $1.3 million — — Strong balance sheet with $ 67.4 million in cash, as of March 31 , 2021— MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , May 11, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced

Read More
Read More

ReWalk Robotics to Report First Quarter 2021 Financial Results on May 11, 2021

05/07/21

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , May 07, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its first quarter 2021 financial results on Tuesday, May 11, 2021 , before the U.S.

Read More
Read More

ReWalk Robotics to Present at the H.C. WAINWRIGHT Global Life Sciences Virtual Conference

03/04/21

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , March 04, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (“ReWalk” or the “Company”) (Nasdaq: RWLK) today announced that Larry Jasinski , Chief Executive Officer and Ori Gon , Chief Financial Officer will present at H.C.WAINWRIGHT global life

Read More
Read More

National Institute for Health and Care Excellence (NICE) Publishes Briefing on ReStore Soft Exo-Suit in the UK

03/03/21

Experts outline potential for improved stroke patient outcomes, cost effectiveness through use of the ReStore device in the rehabilitation setting MARLBOROUGH, Mass. , March 3, 2021 /PRNewswire/ --  ReWalk Robotics, Ltd.  (Nasdaq: RWLK) ("ReWalk" or the "Company"), a manufacturer of robotic medical

Read More
Read More

ReWalk Enters Contract with BKK Mobil Oil health insurance fund for the supply of ReWalk exoskeleton to eligible persons with spinal cord injury in Germany

03/02/21

This supply contract is the first between ReWalk and a German company health insurance fund MARLBOROUGH, Mass. and BERLIN , March 2, 2021 /PRNewswire/ --  ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading manufacturer of robotic medical devices for people with lower

Read More
Read More

ReWalk Robotics Announces Closing of $40.0 Million Private Placement Priced At-the-Market

02/26/21

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Feb. 26, 2021 (GLOBE NEWSWIRE) --   ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced the closing of its previously announced private placement of 10,921,502 ordinary shares and warrants to purchase up to

Read More
Read More

ReWalk Robotics Announces $40.0 Million Private Placement Priced At-the-Market

02/19/21

MARLBOROUGH, Mass. and BERLIN and YOKNEAM ILIT, Israel , Feb. 19, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that it has entered into securities purchase agreements with certain institutional and other accredited investors to raise $40.0

Read More
Read More

ReWalk Robotics Reports Fourth Quarter and Year End 2020 Financial Results

02/18/21

— Annual revenue of $4.4 million in 2020 and $1.2 million for the fourth quarter of 2020 — — Continued CMS progress made with issuance of HCPCS Level II Code for ReWalk Exoskeleton enabling an upcoming application for coverage — — Debt repayment and strengthened cash position allowed going concern

Read More
Read More

ReWalk Robotics to Report Fourth Quarter 2020 Financial Results on February 18, 2021

02/15/21

MARLBOROUGH, Mass. and BERLIN, Germany and YOKNEAM ILIT, Israel , Feb. 15, 2021 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”) today announced that the Company will release its fourth quarter 2020 financial results on Thursday, February 18, 2021 , before the

Read More
Read More
Displaying 73 - 84 of 281